Key findings from the 2024 Mycoplasma genitalium Antimicrobial Resistance Surveillance (MARS) programme

Kirsty F. Bennet, James E. C, Sandhya Vivekanand, Sandra David, Penelope Cliff, Anna Vickers, Rachel Pitt-Kendall, Emma Callan, Katy Sinka, Hamish Mohammed, Sarah Alexander, Helen Fifer, Michelle J. Coleand MARS Collaborators, Blood Safety, HIV Division, UK Health Security Agency, Specialised Microbiology and Laboratories, UK Health Security Agency, The National Institute for Health and Care Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections, University College London in Partnership with the UK Health Security Agency, Institute for Global Health, University College London

International Journal of STD & AIDS: Clinical practice in sexual health

Published online on March 24, 2026

Abstract

International Journal of STD & AIDS, Volume 37, Issue 7, Page 768-777, June 2026.
BackgroundMycoplasma genitaliumis a sexually transmitted pathogen of public health concern due to antimicrobial resistance to the recommended first- and second-line treatments, azithromycin and moxifloxacin. TheM. genitaliumAntimicrobial Resistance ...